Category Archives: Pr Newswire

Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients

LOS ANGELES, Sept. 24, 2024 (GLOBE NEWSWIRE) — Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces a groundbreaking collaboration with PreCheck Health Services Inc., a CLIA-certified and CAP-accredited clinical laboratory specializing in genetic sequencing. The partnership focuses on the development of companion biomarkers for Kairos Pharma’s cancer therapy, ENV105, which targets prostate […]

Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2024 Conference Call for Monday, September 30, 2024

GARDNER, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (Nasdaq: POCI) (the “Company”), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s fourth quarter and fiscal year 2024 financial results on Monday, September […]

LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will […]

Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day

SOUTH SAN FRANCISCO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors or hematologic malignancies, announced today that Lynn Seely, MD, Lyell’s President & CEO, will participate on a panel discussion on next-generation cell therapies […]

Roots Blower Commemorates 170 Years of Engineering Excellence and Innovation in Air and Gas Technology

SINGAPORE, Sept. 25, 2024 /PRNewswire/ — Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and industrial solutions, is excited to announce the remarkable 170th anniversary of Roots, a noteworthy milestone in not only the blower and compressor sector but across all industries. Originally established in the woolen mills of Connersville, Indiana, USA, Roots […]

G7 DFIs, MedAccess, EIB, and IFC Announce MoU for Surge Financing Initiative for Medical Countermeasures

Media Kit: DFC at UNGA 2024 NEW YORK, Sept. 25, 2024 /PRNewswire/ — Today, participating G7 development finance institutions (DFIs), MedAccess, the European Investment Bank (EIB), and the International Finance Corporation (IFC) announced the signing of a memorandum of understanding (MoU) for the Surge Financing Initiative for Medical Countermeasures (MCMs). These DFIs are working closely with global […]

International Team Shield Ignites Global Excitement Ahead of Presidents Cup 2024

LONDON, Sept. 25, 2024 /PRNewswire/ — Over the past week, eagle-eyed golf fans and residents in major cities across the world have spotted a mysterious shield pattern popping up in a variety of locations: Tokyo city centre, the sidewalks of Seoul, a natural area outside of Montreal, graffiti art in Cape Town and a beach […]

Commerce software leader Maropost strengthens leadership team to propel next phase of growth

TORONTO, Sept. 25, 2024 /PRNewswire/ — Maropost, the commerce software suite built for fast-growing retail and ecommerce brands, today announced the appointment of two industry veterans to its executive team: David Charron as Chief Financial Officer (CFO) and Jim Koepke as Chief Revenue Officer (CRO). Ross Andrew Paquette, Chairman and CEO of Maropost, emphasized the […]

EADV Congress 2024: Semaglutide improves outcomes for obese patients with common skin condition, new study shows

A pioneering study, presented today at the EADV Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity. AMSTERDAM, Sept. 25, 2024 /PRNewswire/ — This is the first study to explore the use of semaglutide for HS, marking a critical milestone in the […]

Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results

Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) — Company to host conference call today at 8.30 a.m. ET Continued progress within core activities in RNA delivery, supported by move into new R&D facilities Publications by independent research groups provide fresh evidence of effective mRNA delivery to extrahepatic targets   Major territory expansion with two distribution […]